Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study

被引:32
|
作者
Llanos, Manuel A. [1 ]
Gantner, Melisa E. [1 ]
Rodriguez, Santiago [1 ]
Alberca, Lucas N. [1 ]
Bellera, Carolina L. [1 ]
Talevi, Alan [1 ]
Gavernet, Luciana [1 ]
机构
[1] Natl Univ La Plata UNLP, Dept Biol Sci Fac Exact Sci, Lab Bioact Res & Dev LIDeB, Buenos Aires, DF, Argentina
关键词
MOLECULAR DOCKING; SCORING FUNCTIONS; LIGAND DOCKING; ACCURATE DOCKING; PROGRAMS; GLIDE; PROTONATION; VALIDATION; PREVENTION; INHIBITOR;
D O I
10.1021/acs.jcim.1c00404
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The scientific community is working against the clock to arrive at therapeutic interventions to treat patients with COVID-19. Among the strategies for drug discovery, virtual screening approaches have the capacity to search potential hits within millions of chemical structures in days, with the appropriate computing infrastructure. In this article, we first analyzed the published research targeting the inhibition of the main protease (Mpro), one of the most studied targets of SARS-CoV-2, by docking-based methods. An alarming finding was the lack of an adequate validation of the docking protocols (i.e., pose prediction and virtual screening accuracy) before applying them in virtual screening campaigns. The performance of the docking protocols was tested at some level in 57.7% of the 168 investigations analyzed. However, we found only three examples of a complete retrospective analysis of the scoring functions to quantify the virtual screening accuracy of the methods. Moreover, only two publications reported some experimental evaluation of the proposed hits until preparing this manuscript. All of these findings led us to carry out a retrospective performance validation of three different docking protocols, through the analysis of their pose prediction and screening accuracy. Surprisingly, we found that even though all tested docking protocols have a good pose prediction, their screening accuracy is quite limited as they fail to correctly rank a test set of compounds. These results highlight the importance of conducting an adequate validation of the docking protocols before carrying out virtual screening campaigns, and to experimentally confirm the predictions made by the models before drawing bold conclusions. Finally, successful structure-based drug discovery investigations published during the redaction of this manuscript allow us to propose the inclusion of target flexibility and consensus scoring as alternatives to improve the accuracy of the methods.
引用
收藏
页码:3758 / 3770
页数:13
相关论文
共 50 条
  • [1] Interaction of panduratin A and derivatives with the SARS-CoV-2 main protease (mpro): a molecular docking study
    Vergoten, Gerard
    Bailly, Christian
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (14): : 6834 - 6844
  • [2] Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations
    Chirag N. Patel
    Siddhi P. Jani
    Dharmesh G. Jaiswal
    Sivakumar Prasanth Kumar
    Naman Mangukia
    Robin M. Parmar
    Rakesh M. Rawal
    Himanshu A. Pandya
    [J]. Scientific Reports, 11
  • [3] Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations
    Patel, Chirag N.
    Jani, Siddhi P.
    Jaiswal, Dharmesh G.
    Kumar, Sivakumar Prasanth
    Mangukia, Naman
    Parmar, Robin M.
    Rawal, Rakesh M.
    Pandya, Himanshu A.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
    Thakur, Abhishek
    Sharma, Gaurav
    Badavath, Vishnu Nayak
    Jayaprakash, Venkatesan
    Merz, Kenneth M., Jr.
    Blum, Galia
    Acevedo, Orlando
    [J]. JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2022, 13 (25): : 5776 - 5786
  • [5] Targeting allosteric pockets of SARS-CoV-2 main protease Mpro
    Bhat, Zahoor Ahmad
    Chitara, Dheeraj
    Iqbal, Jawed
    Sanjeev, B. S.
    Madhumalar, Arumugam
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (14): : 6603 - 6618
  • [6] Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study
    Hossain, Rajib
    Mahmud, Shafi
    Khalipha, Abul Bashar Ripon
    Saikat, Abu Saim Mohammad
    Dey, Dipta
    Khan, Rasel Ahmed
    Rauf, Abdur
    Wadood, Abdul
    Rafique, Humaria
    Bawazeer, Sami
    Khalil, Anees Ahmed
    Almarhoon, Zainab M.
    Mabkhot, Yahia N.
    Alzahrani, Khalid J.
    Islam, Muhammad Torequl
    Alsharif, Khalaf F.
    Khan, Haroon
    [J]. MAIN GROUP CHEMISTRY, 2023, 22 (02) : 313 - 327
  • [7] Casiopeinas® as SARS-CoV-2 main protease (Mpro) inhibitors: a combined DFT, molecular docking and ONIOM approach
    Reina, Miguel
    Gabriel Talavera-Contreras, Luis
    Figueroa-DePaz, Yeshenia
    Ruiz-Azuara, Lena
    Felipe Hernandez-Ayala, Luis
    [J]. NEW JOURNAL OF CHEMISTRY, 2022, 46 (26) : 12500 - 12511
  • [8] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Soumya Gulab Katre
    Alpana Jagdish Asnani
    Kumar Pratyush
    Nilima Gangadhar Sakharkar
    Ashwini Gajanan Bhope
    Kanchan Tekram Sawarkar
    Vaibhav Santosh Nimbekar
    [J]. Future Journal of Pharmaceutical Sciences, 8
  • [9] Computational analysis of substrate recognition of Sars-Cov-2 Mpro main protease
    Tasci, Hilal Sena
    Akkus, Ebru
    Yildiz, Muslum
    Kocak, Abdulkadir
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 107
  • [10] Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
    Yang, Yue
    Luo, Yi-Dan
    Zhang, Chen-Bo
    Xiang, Yang
    Bai, Xin-Yue
    Zhang, Die
    Fu, Zhao-Ying
    Hao, Ruo-Bing
    Liu, Xiao-Long
    [J]. ACS OMEGA, 2024, 9 (32): : 34196 - 34219